Doctor Takashi Unoki
Saiseikai Kumamoto Hospital, Kumamoto (Japan)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Combined use of VA-ECMO and Impella (ECPELLA) improves short- and long-term mortality in patients with cardiogenic shock who received VA-ECMO
Event: ESC Congress 2023
Topic: Cardiogenic Shock
Session: Prognostication and mechanical support in cardiogenic shock
Percutaneous coronary intervention on combined VA-ECMO and IMPELLA (ECPELLA) support may reduce myocardial damage in cardiogenic shock patients with STEMI who required mechanical circulatory support
Event: ESC Congress 2021 - The Digital Experience
Topic: Cardiogenic Shock
Session: Acute Cardiac Care ePosters
Combined use of VA-ECMO and IMPELLA (ECPELLA) as a possible strategy to improve outcomes in patients who underwent E-CPR
Event: ESC Congress 2020
Topic: Cardiac Arrest
Session: Mechanic and Ventilatory Support, and Cardiogenic Shock
Growth differentiation factor-15 and mortality in suspected or known coronary heart disease patients with diabetes: a subanalysis of the ANOX study
Event: ESC Congress 2019
Topic: Epidemiology, Prognosis, Outcome
Session: Coronary artery disease - Epidermiology, prognosis and outcome
Vascular endothelial growth factor-C and mortality in patients with suspected but no history of coronary heart disease: a subanalysis of the ANOX study
Event: ESC Congress 2019
Topic: Epidemiology, Prognosis, Outcome
Session: Coronary Artery Disease – Epidemiology, Prognosis, Outcome
Vascular endothelial growth factor-C and mortality in patients with diabetes and suspected coronary artery disease: from the ANOX study
Event: ESC Congress 2018
Topic: Diabetes and the Heart, Other
Session: Diabetes, adiposity and metabolic syndrome
Serum-amyloid-A/LDL complex independently correlated with angiographic severity of coronary artery disease in patients with previous history of cardiovascular events: baseline data from the ANOX study
Event: ESC Congress 2016
Topic: Angina pectoris stable
Session: Diagnostics in stable angina
Serum vascular endothelial growth factor-C levels as an indicator of in-stent restenosis and/or development of coronary new lesion after drug-eluting stent implantation
Event: ESC Congress 2016
Topic: PCI: long-term outcome
Session: Blood markers and reperfusion
ESC 365 is supported by
